Shapely Review: Questions to Settle Before Joining Its Weight-Loss Program

The most useful opening question for Shapely is not simply whether it offers GLP-1 medications. It does. The more revealing question is what, exactly, you would be joining and paying for: a membership, insurance-billed clinical visits, a separate prescription purchase, or some combination. Shapely’s public documentation describes several arrangements, including self-pay compounded injections and help accessing branded medicines. Those arrangements should not be treated as interchangeable offers.

This review examines Shapely’s public documentation consulted October 19, 2026, with an emphasis on questions adults can use before enrollment. The documented service combines video consultations, ongoing weight-management support and medication access when clinically appropriate. However, its pages differ on insured membership pricing, acceptable laboratory-result age and Medicare coverage. The goal is to identify what Shapely explains, what remains unresolved and which answers should come from the program, your clinician, your pharmacy or your health plan.

At a glance

Documented service area: Shapely advertises care for adults 18 and older in California, Florida, New York and Texas; nationwide expansion is described as future.
Sources: [8]
Self-pay membership: The advertised first month is $49, followed by the listed $99 monthly membership price. Medications and laboratory testing are separate.
Sources: [8]
Medication starting prices: Compounded injectable semaglutide starts at an advertised $99 per month within certain three-month packages; injectable tirzepatide starts at $166 per month in its starter package. Membership is additionally required.
Sources: [6] [10]
Ongoing support: The site lists monthly video visits, individual dietitian access, prescription support when appropriate, insurance assistance and unlimited support through chat and its app.
Sources: [8]
Prescription boundary: Shapely’s terms do not guarantee a prescription and allow patients to request transmission of a prescription to their chosen pharmacy.
Sources: [7]

Start with the bill you would actually receive

Shapely’s self-pay membership is listed at $99 per month, with a $49 first-month offer. Its homepage separately promotes a $9 first month when paying with insurance. A UnitedHealthcare page instead lists $49 per month for membership plus applicable copays or deductibles. These are different advertised arrangements, not one universal price. Ask which applies to your enrollment and what the recurring membership charge becomes after any introductory period.

Membership does not include medication or laboratory testing. Shapely says insured patients may also owe copays, deductibles and coinsurance for clinical services, while membership pays for app features, chat, education, tracking tools and help locating medications. Consequently, insurance acceptance does not eliminate the membership charge or establish your prescription cost. A useful written estimate should distinguish the membership, clinical cost-sharing, medicine and any testing rather than presenting a single promotional number.

For uninsured patients, the site advertises laboratory testing for a flat $75 with an in-person draw at Labcorp. Its pricing block describes labs as typically insurance-covered or $75, but that is not an individual benefit determination. Before entering payment information, use these questions beyond the monthly price to request the first charge, the subsequent billing interval and all separately payable services. Shapely’s documentation does not uniformly resolve the insured renewal price.

Sources: [8] [5]

Match the injection price to the package

The injectable medication pages explain why the lowest headline price is not a standard month-to-month rate. Compounded semaglutide’s advertised starting price of $99 per month belongs to specified three-month packages. Compounded tirzepatide’s $166 starting price belongs to its three-month starter package; its low-to-mid refill package is more expensive. Both pages require membership separately. The categories below reproduce commercial pricing distinctions, not instructions for choosing or changing a dose.

The three-month offers display both monthly equivalents and package totals. The consulted documentation does not establish when those totals are collected, whether a package creates a minimum commitment or what supply quantity accompanies each purchase. Shapely advertises Affirm and Klarna, but the reviewed text does not explain financing eligibility, interest or repayment conditions. Ask for the actual payment schedule rather than assuming either mandatory prepayment or unrestricted monthly installments.

Shapely’s semaglutide page says shipping, syringes and alcohol pads are included. Both injection pages advertise free two-day shipping, which does not make the treatment free or establish delivery two days after enrollment. The site also promotes package savings, but the more practical comparison is your applicable package total plus membership and other separate charges. Clarify what happens financially if the clinician changes the treatment plan before a package has been completed.

Advertised compounded injection prices; membership is required separately for every option
Purchase option	Semaglutide injection	Tirzepatide injection
Monthly, low-to-mid category	$139/month	$249/month
Monthly, high category	$179/month	$299/month
Three-month starter package	$99/month; $297 total	$166/month; $498 total
Three-month low-to-mid refill	$99/month; $297 total	$199/month; $597 total
Three-month high-category package	$159/month; $477 total	$279/month; $837 total

Sources: [6] [10]

Ask insurance questions twice: for care and for medicine

Shapely says it is in network with Medicare and most PPO plans, naming Aetna, Blue Shield and United among its examples. Those are the provider’s statements, not independently verified network findings. Its enrollment process asks for insurance information and health goals before a consultation so it can check coverage. Ask what that check includes: clinical visits, dietitian services, prescription benefits and the separate membership may have different financial treatment.

The UnitedHealthcare page explicitly says medication coverage varies by plan and may require prior authorization or evidence of medical necessity. Shapely offers to complete those authorization requests. Its homepage describes commercial-insurance medication copays as typically $25 monthly, while acknowledging higher amounts are possible. Neither statement guarantees approval or your cost. These questions for the program and your health plan can help separate administrative assistance from an insurer’s actual coverage decision.

Medicare deserves additional confirmation because Shapely’s pages do not align. Its Medicare page advertises care from $15 monthly, or free with secondary insurance, under a copays-only message; that is not a medication price. It also claims eligible Part D patients can access specified medicines for $50 monthly through a Medicare GLP-1 Bridge program beginning July 1, 2026. The homepage instead describes coverage limited to diabetes, cardiovascular disease and obstructive sleep apnea. The Bridge claim was not independently verified; request plan-specific confirmation.

Sources: [8] [5] [9]

Establish what the first consultation can decide

Shapely currently advertises service to adults 18 and older in California, Florida, New York and Texas. Its promise of expansion to all 50 states is a future plan, not present nationwide availability. The documented clinical entry point is a video consultation with an assigned provider who personalizes the care plan. The reviewed pages do not establish appointment wait times, a complete intake questionnaire or detailed provider-specific clinical eligibility criteria.

Laboratory instructions need clarification before you arrange a draw. The homepage strongly recommends recent labs before most weight-loss medications but says they are not required for most treatment starts; it accepts results from the preceding six months or offers to order testing. The Medicare page instead accepts results from the preceding 12 months. Ask which window applies to you and which tests the clinician needs before paying to repeat existing work.

Shapely’s terms expressly say a prescription is not guaranteed. They also exclude DEA-controlled or scheduled medicines and certain other drugs with abuse potential. The homepage says people who are not candidates for GLP-1 treatment may be offered other medications, lifestyle modification, continuous glucose monitoring or other tools. That documents possible alternatives, not your eligibility for them. Bring a medication and supplement list, allergies and pregnancy plans for discussion, as NIDDK advises.

Sources: [8] [9] [7] [2]

Get the exact medicine and pharmacy in writing

Shapely’s homepage catalog lists semaglutide under Oral Wegovy, Ozempic and Wegovy, and tirzepatide under Zepbound and Mounjaro. It also lists Foundayo as orforglipron and Contrave as bupropion with naltrexone. These are descriptions of the provider’s advertised catalog, not independent verification of every product’s regulatory status or availability. The accompanying insurance-accepted labels do not establish an indication, a prescription decision or coverage under your particular policy.

Its compounded options are described as custom-prepared prescriptions based on an individual clinical evaluation, potentially using formulations or strengths unavailable commercially. Shapely says these medicines are self-pay only and not reimbursed by insurance. It also says it works exclusively with pharmacies it describes as state-licensed 503A and 503B compounding pharmacies. The consulted text does not name those pharmacies or provide their licenses, leaving an important identification question for enrollment.

FDA approval concerns a specific product, not Shapely or a pharmacy. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that alone does not prove clinical inequivalence. FDA recommends compounded drugs when a patient’s medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. Use these medicine-identification questions to clarify the formulation, route, dispensing pharmacy and clinical reason before comparing prices.

Sources: [8] [6] [1]

Separate prescribing, sourcing and delivery responsibilities

Shapely offers help finding medication at local pharmacies, and its terms let patients instruct Shapely or the provider to send a prescription to their chosen pharmacy. That choice does not establish that every pharmacy can fill every formulation or honor Shapely’s package pricing. For a branded prescription, the site also offers help accessing NovoCare for Wegovy and Lilly Direct for Zepbound, with potential discounts subject to eligibility. Shapely expressly disclaims affiliation with those manufacturers and patient programs.

The injection pages’ free two-day shipping language is a logistical advertisement, not an enrollment-to-treatment timeline. The reviewed documentation does not establish the time needed for consultation, clinical review, prior authorization or medication preparation. Nor does it explain tracking, refrigerated transport, delivery restrictions or responsibility for lost, delayed or damaged shipments. Ask who dispatches the medicine, which organization handles a delivery complaint and whether a replacement would create another charge.

For injectable deliveries, FDA specifically advises not using a GLP-1 product that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy. That guidance is particularly relevant when a service’s public shipping description does not explain temperature handling. Before ordering, obtain the dispensing pharmacy’s contact information and a clear problem-reporting route. The distinction matters: a membership-support representative, a prescribing clinician and a pharmacist may handle different parts of the same delivery problem.

Sources: [8] [7] [6] [10] [1]

Define what ongoing access actually means

Shapely lists monthly video visits with a weight-loss provider, individual access to a personalized dietitian and unlimited support through chat and its app. It also advertises help with insurance coverage and locating medication. These are meaningful service components, but unlimited support does not establish an immediate response or round-the-clock clinician availability. Ask which team members answer messages, when a concern becomes a clinical visit and how time-sensitive medication questions are escalated.

The site advertises a cellular-enabled scale for use during the program, with an explicit restriction: it is unavailable when Aetna or Cigna is the primary insurance. Ask whether your enrollment includes the device and whether there are return requirements when care ends; the reviewed text does not settle that latter issue. Likewise, do not assume Spanish-language visits, interpreters or multilingual clinical materials are available. Those services were not confirmed in the consulted documentation.

The terms warn that text messages and email may not be encrypted and could be intercepted. Ask which channel Shapely intends for sensitive clinical information and how to reach the prescribing team securely. Ongoing access should also mean more than receiving renewals: NIDDK describes follow-up as attention to treatment response and tolerability. A practical question is how Shapely’s monthly visits and dietitian support are coordinated when symptoms, access problems or changing costs disrupt the original plan.

Sources: [8] [7] [2]

Resolve ownership of care—and the exit terms

The terms identify the business as Zaghi Medical, Inc., doing business as Shapely. Their description of clinical relationships is less consistent: one passage refers to providers employed or contracted by Shapely, while another says Shapely does not employ, supervise or control the providers delivering care. That discrepancy does not establish who treats a particular patient. Ask for the treating clinician’s identity, credentials, clinical organization and the contact responsible for complaints or continuity of care.

The reviewed terms were incomplete, including an omitted middle portion, and the available documentation does not establish automatic-renewal rules, cancellation deadlines, refund eligibility, medication returns or early departure from three-month packages. This is an information gap, not evidence of a particular policy. Request the full current agreement and written answers to these questions before the next charge. Stopping future membership billing and obtaining a refund for a previous payment are separate questions.

Finally, Shapely discloses that customer testimonials are shared with permission and that usage rights were compensated; it also says results vary. Those disclosures are worth retaining when weighing the marketing against the service description. Testimonials do not establish your likely outcome or verify the performance of a compounded formulation. A stronger decision basis is a documented care plan, a complete price breakdown and clear responsibility when medication access, tolerability or the relationship with the service changes.

Sources: [7] [8] [2] [3] [4]

Questions & answers

Can I join Shapely from any U.S. state?

Not based on the documented availability. Shapely advertises care for adults 18 and older in California, Florida, New York and Texas. Its statement about serving all 50 states describes planned expansion. Confirm availability before paying, particularly if you live elsewhere or expect to move during care.

Sources: [8]

Does the $99 semaglutide offer include membership?

No. The injectable semaglutide page ties $99 per month to three-month starter and low-to-mid refill packages, each listed at $297 total. Membership is additionally required. The ordinary monthly low-to-mid category is $139, and the high category is $179. Ask when the package total is collected and which membership price applies.

Sources: [6] [8]

Will Shapely guarantee insurance approval for my medication?

No documented guarantee establishes that. Shapely offers coverage assistance and prior-authorization work, but its UnitedHealthcare page says benefits vary by plan. Its advertised typical $25 commercial-insurance medication copay can be higher. Ask your plan to confirm the specific medicine, authorization requirements and pharmacy cost separately from coverage for Shapely visits.

Sources: [5] [8]

Can I use laboratory results I already have?

Possibly, but Shapely’s pages give different windows. The homepage accepts results from six months before enrollment, while the Medicare page states 12 months. Ask the clinical team which rule and test requirements apply to you. Uninsured testing is advertised at $75 with an in-person Labcorp draw.

Sources: [8] [9]

Can I send a Shapely prescription to my own pharmacy?

The terms expressly allow you to request transmission to your chosen pharmacy. That does not guarantee the pharmacy stocks the medicine, can prepare a particular compounded formulation or will match Shapely’s advertised pricing. Confirm the dispensing arrangement and price before assuming a prescription transfer preserves a package offer.

Sources: [7] [6]

What should I obtain before buying a three-month package?

Request the collection schedule, full membership terms, cancellation procedure, refund boundaries and what happens if treatment changes. Shapely displays package totals and advertises Affirm and Klarna, but the reviewed documentation does not resolve those financial and exit details. A three-month package label alone does not establish supply quantity or a minimum commitment.

Sources: [6] [10] [7]

Our assessment

Shapely documents a more involved service than prescription access alone: monthly video visits, dietitian access, messaging and insurance-navigation support are central to its offer. Its medication pages also provide useful category and package prices. The main decision barrier is reconciling those details into one dependable agreement for your circumstances. Insured pricing, Medicare descriptions, laboratory windows, pharmacy identity and exit terms need clarification. Before enrolling, obtain a written breakdown of recurring costs, the exact medication and dispensing arrangement, and who handles clinical and billing problems. Clear answers would make the documented service easier to evaluate; unresolved promotional differences should not substitute for those answers.

Visit Shapely’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Shapely Review: Questions to Settle Before Joining Its Weight-Loss Program

At a glance

01Start with the bill you would actually receive

02Match the injection price to the package

03Ask insurance questions twice: for care and for medicine

04Establish what the first consultation can decide

05Get the exact medicine and pharmacy in writing

06Separate prescribing, sourcing and delivery responsibilities

07Define what ongoing access actually means

08Resolve ownership of care—and the exit terms